Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $38.1000 (-1.68%) ($37.8000 - $39.3600) on Tue. Nov. 27, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.81% (three month average) | RSI | 54 | Latest Price | $38.1000(-1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.905% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-11%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.905% (StdDev 3.81%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
5 Day Moving Average | $37.78(0.85%) | 10 Day Moving Average | $36.7(3.81%) | 20 Day Moving Average | $36.35(4.81%) | To recent high | -12.4% | To recent low | 20.5% | Market Cap | $2.831b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |